The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Open accessPublished version of a preprint
Abstract
Cellular senescence suppresses cancer by irreversibly arresting cell proliferation. Senescent cells acquire a proinflammatory senescence-associated secretory phenotype. Many genotoxic chemotherapies target proliferating cells nonspecifically, often with adverse reactions. In accord with prior work, we show that several chemotherapeutic drugs induce senescence of primary murine and human cells. Using a transgenic mouse that permits tracking and eliminating senescent cells, we show that therapy-induced senescent (TIS) cells persist and contribute to local and systemic inflammation. Eliminating TIS cells reduced several short- and long-term effects of the drugs, including bone marrow suppression, cardiac dysfunction, cancer recurrence, and physical activity and strength. Consistent with our findings in mice, the risk of chemotherapy-induced fatigue was significantly greater in humans with increased expression of a senescence marker in T cells prior to chemotherapy. These findings suggest that senescent cells can cause certain chemotherapy side effects, providing a new target to reduce the toxicity of anticancer treatments. Significance: Many genotoxic chemotherapies have debilitating side effects and also induce cellular senescence in normal tissues. The senescent cells remain chronically present where they can promote local and systemic inflammation that causes or exacerbates many side effects of the chemotherapy. Cancer Discov; 7(2); 165–76. ©2016 AACR. This article is highlighted in the In This Issue feature, p. 115
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, through SASP, senescent cells contribute to cancer development162,163 and metastasis164, treatment failure and increased risk of recurrence165.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [165]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The SASP can also explain chemotherapy side effects, such as bone marrow suppression, cardiac dysfunction, blood clotting, or cancer relapse (Demaria et al. 2017; Wiley et al. 2019).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Demaria et al. 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
From Length-independent telomere damage drives post-mitotic cardiomyocyte senescence (2019) · cites this paper as Demaria et al, 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cellular senescence, a central hallmark of aging,13,14 encompasses heterogeneous cellular states triggered by prolonged cell stress resulting in the irreversible arrest of proliferation and permanent changes to cell function in vivo.15,16,17,18,19”
From Uncovering the signatures of aging and senescence in the human dorsolateral prefrontal cortex (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, these detrimental effects were neutralized via genetic or pharmacological clearance of senescent cells 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, high expression of p16 INK4a in circulating Tcells before treatment, presumably a surrogate biomarker of system-wide senescent cell burden, correlates with severe chemotherapy- induced fatigue in patients with breast cancer, suggesting that senescent cells might contribute to the reduced tolerance of older individuals to anticancer therapies 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in mouse models have demonstrated that TIS promotes cardiac dysfunction, inflammation, bone loss, muscle weakness, renal and hepatic failure, haematopoietic insufficiency, and overall frailty 27,111,202 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with cancer, older age (>65 years) is associated with reduced tolerance to anticancer treatment 27 and a greater risk of developing serious AEs 192 , as well as genetic alterations that might lead to reduced sensitivity to treatment; together these features constitute major hurdles for the successful administration of antineoplastic therapies at efficient doses.”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Therapy-induced senescence plays an important role in determining the outcome of anti-cancer treatment 40, whilst also being responsible for some of its side effects 41.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“These include increases in local and systemic inflammation and cancer reoccurrence (Demaria et al. 2017).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Demaria et al. 2017
The cited source says what the claim attributes to it.
In the citing paper
“In some cases, these triggers cause fibroblasts to enter a non-proliferative state termed ‘senescence’71, which is distinct from the phenotype of an aged fibroblast.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [71]
The cited source says what the claim attributes to it.
In the citing paper
“For example, DOX-induced systemic senescence was found to promote metastasis in an orthotopic mouse model of breast cancer.”
From Drug repurposing for cancer therapy (2024) · cites this paper as [232]
The cited source says what the claim attributes to it.
In the citing paper
“p16 INK4a expression is considered a common and robust, albeit not necessarily specific, marker of senescence, and its promoter activity and transcriptional activation are extensively exploited as reporters of senescent cells invivo 20,23,27,28 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Alkylating agents 27,95,96 (for example, cisplatin, cyclophosphamide and temozolomide), topoisomerase inhibitors 27,65,91,95 (such as doxorubicin, etoposide and camptothecin) and γ- irradiation 78 , but also microtubule inhibitors 27,97,98 (for example, paclitaxel) and, to a lesser extent, vinca alkaloids 78 (for example, vincristine), have all been identified as senescence inducers in preclinical”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“In tumour- free mice, exposure to the topoisomerase II inhibitor doxorubicin leads to systemically elevated SASP and functional impairment reminiscent of accelerated ageing, which is only explained in part by direct organ toxicity of this chemotherapeutic agent 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Doxorubicin- induced systemic senescence contributed to breast cancer metastasis in an orthotopic mouse model.”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, high expression of p16 INK4a in circulating Tcells before treatment, presumably a surrogate biomarker of system-wide senescent cell burden, correlates with severe chemotherapy- induced fatigue in patients with breast cancer, suggesting that senescent cells might contribute to the reduced tolerance of older individuals to anticancer therapies 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
In the citing paper
“SASP also mediates the harmful effects of senescent cells which accumulate upon chemotherapy treatment as their chronic presence promotes local and systemic inflammation.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“age-related or therapy-induced senescent cells are mainly linked with secretion of inflammatory factors (Baker et al., 2016; Demaria et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“Elimination of therapy-induced senescent cells can prevent cancer recurrence (Demaria et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“Moreover, senescent cells have been implicated in the adverse effects of some chemotherapeutic regimens as well as in the recurrence of specific neoplasms, at least in mice [969].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [969]
In the citing paper
“whilst also contributing to their side effects 41.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [41]
In the citing paper
“Via the SASP, senescent cells contribute to multiple chronic health conditions associated with inflammaging, e.g., atherosclerosis (16), osteoarthritis (17), cancer (18), myeloid skewing in the bone marrow (19), pulmonary fibrosis (20), Alzheimer’s disease and Parkinson’s disease (21–23), and insulin resistance (24).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [18]
In the citing paper
“These persisting senescent cells have been recently tied to multiple chronic diseases other than atherosclerosis, including diabetes mellitus,85 obesity,85 Alzheimer’s disease,86 heart failure,10,87 idiopathic pulmonary fibrosis,88,89 chronic obstructive pulmonary disease,90 chronic kidney disease,91 cancer,92 and osteoarthritis.93”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [92]
In the citing paper
“However, chronic senescence promotes cancer.92”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [92]
In the citing paper
“and paradoxically tumorigenesis (Demaria et al., 2017).”
From Telomeres and cell senescence—size matters not (2017) · cites this paper as Demaria et al., 2017
In the citing paper
“However, senescence may contribute to reduced patient resilience to cancer therapies”
From Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies (2020) · cites this paper as [67]
In the citing paper
“The use of senotherapeutic drugs could potentially be effective in treating a variety of conditions primarily or secondarily mediated by accumulation of senescent cells [6, 33, 67–87].”
From Reducing Senescent Cell Burden in Aging and Disease (2020) · cites this paper as [69]
In the citing paper
“The development of a tumor cell population that escapes from senescence and restarts proliferating may contribute to cancer relapse [342].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [342]
In the citing paper
“Senescent cells have also been postulated to mediate resistance to therapy, while contributing to off-target systemic effects and cancer relapse linked to the treatment with standard anticancer regimens.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [200]
In the citing paper
“In the same model, whole-body clearance of p16 + cells generated by doxorubicin treatment reduces signs of systemic frailty and limits tumor recurrence.200”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [200]
In the citing paper
“Indeed, persistent senescent cells may contribute to detrimental short and long-term side effects of treatment, as well as to metastases and relapse (Demaria et al., 2017).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Demaria et al., 2017
In the citing paper
“the elimination of therapy-induced senescent cells reduced several side-effects of chemotherapy and even cancer recurrence in mice14.”
From A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells (2020) · cites this paper as [14]
In the citing paper
“Furthermore, ablation of senescent cells after chemotherapy can prevent or delay cancer relapse and spread to distal tissues.59”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Moreover, senescent cells accumulate with age in several vertebrate organisms (1), and their elimination can delay the onset of several age-associated disorders in mice (3, 4).”
BackgroundAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“Moreover, senescent cells accumulate with age in several vertebrate organisms (1), and their elimination can delay the onset of several age-associated disorders in mice (3, 4).”
BackgroundInfluentialSelf-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Self-citationDoxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,870
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y. G., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,842
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Self-citationInk4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Kuil, L. E., Coppola, N., Dietrich, J., & Castel, H. (2025) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2025.2539199 · Cited by 7
Xing, T., Hu, Y., Wang, H., & Zou, Q. (2023) · Medicine · doi:10.1097/md.0000000000033739 · Cited by 7
Hua, H., Zhao, Q., Xia, J., Dai, Q., Bai, S.-R., Wang, X., & Zhou, M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110630 · Cited by 7
Gene expression signatures of human senescent corneal and conjunctival epithelial cells
Kitazawa, K., Matsumoto, A., Numa, K., Tomioka, Y., Zhang, Z. A., Yamashita, Y., Sotozono, C., Desprez, P., & Campisi, J. (2023) · Aging · doi:10.18632/aging.205113 · Cited by 7
Self-citationQuercetin Nano-formulations as a Potential Approach for Skin Cancer
Kapare, H. S., Kanadje, S., & Bhole, R. P. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385332427241112034005 · Cited by 7
Escriche‐Navarro, B., Garrido, E., Escudero, A. C., Montoya-Méndez, I., Sancenón, F., García‐Fernández, A., & Martínez‐Máñez, R. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123461 · Cited by 7
Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners
Nadaradjane, C., Yang, C. H., Rodriguez‐Gabin, A., Ye, K. Q., Sugasawa, K., Atasoylu, O., Smith, A. B., Horwitz, S. B., & McDaid, H. M. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b00111 · Cited by 7
Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo
Moniot, A., Braux, J., Bour, C., Guillaume, C., Lamret, F., Allart‐Simon, I., Audonnet, S., Renault, S., Rédiní, F., Laronze‐Cochard, M., et al. (2021) · Cancers · doi:10.3390/cancers13235992 · Cited by 7
Oral Senescence: From Molecular Biology to Clinical Research
Parkinson, E. K., & Prime, S. S. (2022) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2022.822397 · Cited by 7
Agrawal, K., Das, V., Kudlová, N., Gurský, J., Džubák, P., & Hajdúch, M. (2018) · Stem Cells International · doi:10.1155/2018/6013728 · Cited by 7
Diagnostic approaches of pneumonia for commercial-scale biomedical applications: an overview
Bakare, O. O., Fadaka, A. O., Klein, A., Keyster, M., & Pretorius, A. (2020) · All Life · doi:10.1080/26895293.2020.1826363 · Cited by 7
Maintenance and repair of an aging life cycle
Baar, M. P., van Willigenburg, H., & de Keizer, P. L. J. (2017) · Oncotarget · doi:10.18632/oncotarget.18046 · Cited by 7
Overview of molecular signatures of senescence and associated resources: pros and cons
Ntintas, O. A., Vagena, S., Pantelis, P., Theocharous, G., Petty, R., Evangelou, K., & Gorgoulis, V. G. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70134 · Cited by 6
Bugia, L., Affolter, A., Kern, J., Sohn, E., Jungbauer, F., Fleckenstein, J., Lammert, A., Rotter, N., & Scherl, C. (2025) · Oncology Reports · doi:10.3892/or.2025.8984 · Cited by 6
Menéndez, J. A., Lupu, R., Martín-Castillo, B., Josep Sardanyés, A., Alarcón, T., Verdura, S., & Cuyàs, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695244 · Cited by 6
Hamburger, E. C. B., Brigato, P., Rosenzweig, D. H., & Haglund, L. (2026) · BMC Cancer · doi:10.1186/s12885-026-15650-x · Cited by 6
Recent Advances in Senotherapeutics Delivery
Choi, J. Y., Yee, S. F., Tchangalova, T., Yang, G., & Fisher, J. P. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0212 · Cited by 6
Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP)
Malaquin, N., & Rodier, F. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.10.005 · Cited by 6
Oliveros, A., Poleschuk, M., Cole, P. D., Boison, D., & Jang, M. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.08.003 · Cited by 6
Cellular senescence and nanoparticle-based therapies: Current developments and perspectives
Henschke, A., Mielcarek, A., Grześkowiak, B. F., Perrigue, P. M., Jaskot, K., Coy, E. L., & Moya, S. E. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0211 · Cited by 6
Neuregulin-1 reduces Doxorubicin-induced cardiotoxicity by upregulating YAP to inhibit senescence
Shi, H., Zou, Y., Li, Y., Li, Y., & Liu, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113278 · Cited by 6
Human umbilical cord mesenchymal stem cell-derived exosome ameliorate doxorubicin-induced senescence
Yang, Z., Yan, F., Yuan, J., Yang, M., Wang, J., You, C., & Ren, K. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114450 · Cited by 6
Zhang, Z., Zhou, J., Huang, R., Zhuang, X., & Ni, S. (2025) · Discover Oncology · doi:10.1007/s12672-025-02182-2 · Cited by 6
The adverse effects of chemotherapy on bone mass are not prevented by senolytics
Ali, M. M., Simmons, P., Warren, A. D., Gatrell, L. B., Resende-Coelho, A., McElroy, T., Allen, A. R., & Almeida, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-01717-5 · Cited by 6
Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer
Gong, D. H., Liu, R., Cui, Y., Rhodes, M., Bae, J. W., Beechem, J., & Hwang, W. L. (2025) · Science Advances · doi:10.1126/sciadv.adx0632 · Cited by 6
Aging is an adaptation that selects in animals against disruption of homeostasis
Muller, A. W. J. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.07.020 · Cited by 6
Science‐in‐brief: The importance of senescence in tendinopathy: New opportunities
Kelly, E. F., Smith, R. K. W., Dudhia, J., & Faragher, R. (2020) · Equine Veterinary Journal · doi:10.1111/evj.13228 · Cited by 6
Life after Cell Death—Survival and Survivorship Following Chemotherapy
McErlain, T., Burke, A., & Branco, C. M. (2021) · Cancers · doi:10.3390/cancers13122942 · Cited by 6
Solving the enigma: Mass spectrometry and small molecule probes to study sphingolipid function
Millner, A., & Atilla‐Gokcumen, G. E. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.05.001 · Cited by 6
Cox, L. S. (2022) · The Journal of the Economics of Ageing · doi:10.1016/j.jeoa.2022.100423 · Cited by 6
Iron-loaded extracellular vesicles: angel or demon?
Chen, H., & Tang, Y. (2023) · Free Radical Research · doi:10.1080/10715762.2023.2191813 · Cited by 6
Zhang, X.-X., Yu, X., Zhu, L., & Luo, J.-H. (2023) · Medicine · doi:10.1097/md.0000000000035923 · Cited by 6
Walczak, Ł. J., Szopa, A., Pitucha, M., Serefko, A., Pachuta‐Stec, A., Pawłowski, K., Gawrońska‐Grzywacz, M., Lachowicz, J. I., & Herbet, M. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105741 · Cited by 6
Guo, Y., Wang, S., Dong, Y., & Liu, Y. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114371 · Cited by 6
Cellular senescence: A potential mode of circular RNAs regulating prostate cancer
Li, Y., Fan, A., Zhang, Y., Guo, Z., Meng, W., Pan, W., Ma, Z., & Chen, W. (2023) · MedComm – Oncology · doi:10.1002/mog2.61 · Cited by 6
Chemo-Senolytic Therapeutic Potential against Angiosarcoma
Wang, X., Chung, C., Yoshioka, A., Hashimoto, S., Jimbo, H., Tanizawa, H., Ohta, S., Fukumoto, T., & Noma, K.-I. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.026 · Cited by 6
Christian, L. M., Kiecolt‐Glaser, J. K., Cole, S. W., Burd, C. E., Madison, A. A., Wilson, S. J., & Rosko, A. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.019 · Cited by 6
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer
Chowdhury, S. R., Murphy, K. C., Parikh, C. N., DeMarco, K. D., Zhou, L., & Ruscetti, M. A. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.07.010 · Cited by 6
Ju, G., Lin, Q., Lu, L., Lin, Z., Huang, D., Lin, Y., Huang, X., Lin, Q., Xu, H., Bai, Y., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143543 · Cited by 6
Lázničková, P., Kepák, T., Kohoutková, M. H., Horváth, L., Sheardová, K., Marciniak, R., Vacca, C., Šiklová, M., Zelante, T., Rossmeislová, L., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048541 · Cited by 6
Pacifico, F., Crescenzi, E., & Leonardi, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1669-7_12 · Cited by 6
Erçelik, M., Tunca, B., Aksoy, S. A., AKSOY, Ç. A., & Tezcan, G. (2022) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2022.57639 · Cited by 6
Liu, X., Zhang, K., Jie, T., Li, J., Jiang, Y., & Wang, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1067682 · Cited by 6
Glypican1: A potential cancer biomarker for nanotargeted therapy
Tripathi, A. D., Katiyar, S., & Mishra, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103660 · Cited by 6
Senescent characteristics of human corneal endothelial cells upon ultraviolet-A exposure
Numa, K., Patel, S. K., Zhang, Z. A., Burton, J. B., Matsumoto, A., Hughes, J. B., Sotozono, C., Schilling, B., Desprez, P., Campisi, J., et al. (2024) · Aging · doi:10.18632/aging.205761 · Cited by 6
Self-citationHe, Y., Zheng, G., & Zhou, D. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_1 · Cited by 6
Self-citationGuo, B., Rodriguez‐Gabin, A., Prota, A. E., Mühlethaler, T., Zhang, N., Ye, K. Q., Steinmetz, M. O., Horwitz, S. B., Smith, A. B., & McDaid, H. M. (2020) · Molecular Pharmacology · doi:10.1124/mol.119.117457 · Cited by 6
Henze, L., Walter, U., Escobar, H. M., Junghanß, C., Jaster, R., Köhling, R., Lange, F., Salehzadeh‐Yazdi, A., Wolkenhauer, O., Hamed, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039560 · Cited by 6
Yang, Y., Chen, X., Han, H., Sun, J., Chen, S., Yang, C., Ma, Q., & Yang, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-98913-w · Cited by 6
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac112.96049618 · Cited by 6
Establishment of a cell senescence related prognostic model for predicting prognosis in glioblastoma
Li, H., Wang, Z., Sun, C., & Li, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1034794 · Cited by 6
Gene expression profiling of hypoxic response in different models of senescent endothelial cells
Mongiardi, M. P., Merolle, M., Fustaino, V., Levi, A., & Falchetti, M. L. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01390-5 · Cited by 6
Cole, A. R., Buj, R., Uboveja, A., Levasseur, E., Tom, A., Wang, H., Kedziora, K. M., Chatoff, A. G., Huacachino, A. A., Marcinkiewicz, M. M., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01172-5 · Cited by 5
Lin, S., Ma, L., Mo, J., Zhao, R., Li, J., Yu, M., Jiang, M., & Peng, L. (2024) · Aging · doi:10.18632/aging.205778 · Cited by 5
Harnessing Senescence for Antitumor Immunity to Advance Cancer Treatment
Prasanna, P. G. S. (2024) · Radiation Research · doi:10.1667/rade-24-00098.1 · Cited by 5
Xie, Y., Luo, X., Di, X., Li, J., Xia, Y., Wang, L., & Liu, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02543 · Cited by 5
Ma, Y., Yi, C., Cai, N., & Chen, J. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-06017-5 · Cited by 5
Casso-Chapa, B., González, N. A. V., Le, N., Palaskas, N. L., Nead, K. T., Eutsey, L. P., Samanthapudi, V. S. K., Osborn, A. M., Lee, J., Mejia, G. F., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319870 · Cited by 5
Identification the Cellular Senescence Associated lncRNA LINC01579 in Gastric Cancer
He, J., Fu, Z., Zou, B., Lei, X., Lei, L., Yang, Q., & Li, G. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70360 · Cited by 5
Pharmacological frontiers in senescence: Transforming senescence with drug repurposing
Shahzadi, A., Özyazgan, S., & Çakatay, U. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.02.010 · Cited by 5
Chen, Y., Ye, Z., He, R., Chen, G., & Zhang, D. X. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.009 · Cited by 5
Han, C. J., Rosko, A. E., Plascak, J. J., Tan, A., Noonan, A. M., & Burd, C. E. (2025) · Current Oncology · doi:10.3390/curroncol32080438 · Cited by 5
Huang, P., Jing, R., Zhang, W., Xia, J., Luan, X., Ye, J., Tian, S., Zhang, H., Wang, Q., Jiang, H., et al. (2025) · Engineering · doi:10.1016/j.eng.2025.08.019 · Cited by 5
Self-citationSenescence-associated gene signatures predict survival in lung cancer: a multi-cohort analysis
Ungvari, Z. I., Menyhárt, O., Ocaña, A., Fekete, M., Lehoczki, A., & Győrffy, B. (2025) · GeroScience · doi:10.1007/s11357-025-01894-1 · Cited by 5
Skin aging and immunosenescence
Štrbo, N., Younis, S., Frasca, D., & Paganelli, A. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003218 · Cited by 5
Senescent human fibroblasts have increased FasL expression and impair the tumor immune response
Cruz-Barrera, M., Dulong, J., Nehmo, G. M., Sonn, A., Moquin‐Beaudry, G., Benabdallah, B., Lê, O., & Beausejour, C. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1685269 · Cited by 5
Senotherapeutics in Malignant Brain Cancer Therapy
Kaina, B., & Christmann, M. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01733-8 · Cited by 5
Wang, X., Ma, H., Li, Y., Chen, L., Ye, C., Zhao, Y., Wang, H., Fu, W., Yu, C., Wang, F., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70810-8 · Cited by 5
Telomere Length in Adolescent and Young Adult Survivors of Childhood Cancer
Park, M., Lee, D.-E., Hong, Y., Suh, J. K., Lee, J. A., Kim, M., & Park, H. J. (2024) · Cancers · doi:10.3390/cancers16132344 · Cited by 5
Uncovering cellular senescence as a therapeutic target in NF2-related vestibular schwannoma
Franco-Caspueñas, S., García‐Montoya, C., Contreras, J., Lassaletta, L., Varela‐Nieto, I., & Jimenez-Lara, A. M. (2024) · Hearing Research · doi:10.1016/j.heares.2024.109165 · Cited by 5
Frosted DNA: β‐Galactosidase Control of Oligonucleotide Activity
Sinsel, F., Külp, M., Rieger, M. A., & Heckel, A. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202500347 · Cited by 5
Santos‐Sousa, D., da Rosa, S., & Filippi‐Chiela, E. C. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112052 · Cited by 5
Age-dependent cytokine surge in blood precedes cancer diagnosis
Chen, G., Mohsin, A., Zheng, H., Rosenberg‐Hasson, Y., Padilla, C., Sarin, K. Y., Dekker, C. L., Grant, P., Maecker, H. T., Lü, Y., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420502122 · Cited by 5
Cellular senescence as a source of chronic microinflammation that promotes the aging process
Nakanishi, M. (2025) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.101.014 · Cited by 5
Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma
Zhu, Z.-G., Chen, L., Miao, D.-L., Jin, Y., & Wu, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.941389 · Cited by 5
Text mining for contexts and relationships in cancer genomics literature
Collins, C., Baker, S., Brown, J. P., Zheng, H., Chan, A. S. L., Stenius, U., Narita, M., & Korhonen, A. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae021 · Cited by 5
Suzuki, M., Kobayashi, H., Hara, D., & Hanaoka, H. (2024) · Cancer Medicine · doi:10.1002/cam4.7381 · Cited by 5
Development of a cyclophosphamide stress test to predict resilience to aging in mice
Zhu, L., Dou, Y., Bjorner, M., & Ladiges, W. (2020) · GeroScience · doi:10.1007/s11357-020-00222-z · Cited by 5
[Preparation of warangalone-loaded liposomes and its inhibitory effect on breast cancer cells].
Mao, L., Liu, H., Liu, H., Bian, Z., Zhang, Q., Liao, W., & Sun, S. (2020) · PubMed · doi:10.12122/j.issn.1673-4254.2020.06.16 · Cited by 5
Kazemi, M., Ashjari, M., & Nazarabi, M. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1890769 · Cited by 5
Bowen, D. J., Rentscher, K. E., Wu, A. Y., Darien, G., Haile, H. G., Mandelblatt, J. S., & Kavanaugh-Lynch, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136999 · Cited by 5
Buchsbaum, J. C., Espey, M. G., Obcemea, C., Capala, J., Ahmed, M. M., Prasanna, P. G., Vikram, B., Hong, J. A., Teicher, B., Aryankalayil, M. J., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02579 · Cited by 5
Glucomannogalactan inhibits senescence by promoting nuclear translocation of NRF2
Liang, Z., Tang, Q., Liang, H., Liang, X., Fu, C., Kang, W., Zhang, Y., & Lv, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141059 · Cited by 4
Pain, fatigue, and associated gene expressions over chemotherapy in patients with colorectal cancer
Wu, W., Li, A., Singh, V., Salner, A., Chen, M., Judge, M. P., Cong, X. S., & Xu, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325849 · Cited by 4
Wang, Z., Wu, X., Dai, Q., Liu, Z., Zhao, C., Wei, L. T., Zhao, Y., Li, L., & Wang, X. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103666 · Cited by 4
Senescent cancer cells in immune surveillance and evasion: mechanisms and therapeutic implications
De-chang, L., Wang, J., Wei, Y., Wu, H. Y., Yuan, S., Yang, M. J., & Sun, L. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf125 · Cited by 4
Potential connections between senescence and chemobrain: An early overview of literature
Melhem, N. Y., Qutifan, S., Alsalem, M., & Saleh, T. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102896 · Cited by 4
Chuang, Y., Wu, C., Chang, W., Su, Y., Hsu, H., Lin, F., & Lo, Y. (2025) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70117 · Cited by 4
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Lin, C., Hadfield, M. J., Rathore, A., Pinho-Schwermann, M. P., Zhang, S., Lu, S., den Hollander, P., Mani, S. A., Seyhan, A. A., Santopietro, A., et al. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103061 · Cited by 4
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
Sobeai, H. M. A., Alanazi, A. M., Alotaibi, F., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Almudimeegh, S., al-Ramadi, B. K., Chakraborty, E., Saleh, T. M., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1661424 · Cited by 4
Choi, M., Lee, D., Yang, W.-H., & Cha, J. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08688-z · Cited by 4
Wang, B., Piccolantonio, A., Altulea, A., Huang, M., Joshi, T., Pagliarin, F., Palma, M. D., Lin, Y., Mackedenski, S. J., Ustyantsev, K., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01168-1 · Cited by 4
Self-citationGunturu, D. R., Hassan, M. I., Bedi, D., Datta, P. K., Manne, U., & Samuel, T. (2024) · Current Oncology · doi:10.3390/curroncol31030089 · Cited by 4
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Elshazly, A. M., Shahin, U., Shboul, S. A., Gewirtz, D. A., & Saleh, T. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000871 · Cited by 4
Non-ionizing radiation-induced cellular senescence and age-related diseases
Wang, H., Tong, J., & Cao, Y. (2024) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2024.04.002 · Cited by 4
Nishimura, J., Morita, Y., Tobe‐Nishimoto, A., Kitahira, Y., Takayama, S., Kishimoto, S., Matsumiya, Y., Takeshita, A., Matsunaga, K., Imai, T., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112377 · Cited by 4
Bar, S., Hilsabeck, T. A. U., Pattavina, B., López-Domínguez, J. A., Basisty, N., Bons, J., Watson, M., Schilling, B., Campisi, J., Kapahi, P., et al. (2025) · Aging · doi:10.18632/aging.206224 · Cited by 3
Self-citationUncovering the signatures of aging and senescence in the human dorsolateral prefrontal cortex
Sloan, N. X., Mares, J., Daly, A. C., Grier, S., Haq, I., Jackson, C. A., Barretto, N., Casel, O., Kang, K., Khiste, S., et al. (2026) · Cell Genomics · doi:10.1016/j.xgen.2025.101127 · Cited by 2
Metadata
- Authors
- Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., Alston, S., Academia, E. C., Kilmarx, S., Valdovinos, A., Wang, B., de Bruin, A., Kennedy, B. K., Melov, S., Zhou, D., Sharpless, N. E., Muss, H., & Campisi, J.
- Affiliations
- University Medical Center Groningen (NL)
- 1Buck Institute for Research on Aging, Novato, California.
- University of Arkansas for Medical Sciences (US)
- Buck Institute for Research on Aging (US)
- 4HealthSpan Diagnostics, Research Triangle Park, North Carolina.
- University of North Carolina at Chapel Hill (US)
- 6Department of Pathobiology, University of Utrecht, Utrecht, the Netherlands.
- Corresponding author
- Demaria, Marco
- Campisi, Judith
- ORCID
- Venue
- Cancer Discovery
- Published
- 2017-02-01
- Volume
- 7
- Issue
- 2
- Pages
- 165-176
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC5296251
- OpenAlex
- W2561396377
- Cited by
- 1,338
- References
- 34
- Citations by year
- 2026: 113 · 2025: 153 · 2024: 164 · 2023: 176 · 2022: 198 · 2021: 152 · 2020: 159 · 2019: 105 · 2018: 79 · 2017: 38
- FWCI
- 59.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- UNC Libraries
- Funders
- American-Italian Cancer Foundation
- National Institutes of Health (5r01ag024379-15, AG009909, AG017242, AG041122)
- National Institute on Aging (R56AG009909, R01-AG024379, R37AG009909, P01AG041122, P01AG017242)
- National Cancer Institute (R01CA122023, R01CA166347, R01CA203023, R01CA163896, P30CA016086)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- cellular senescence, therapy-induced senescence, chemotherapy toxicity, senescence-associated secretory phenotype, senolytics, senescent cell elimination, inflammation, tumor recurrence, myelosuppression, cardiotoxicity, chemotherapy-induced fatigue, T cells, genotoxic chemotherapy, transgenic mouse model
- MeSH terms
- Animals, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Mice, Transgenic, Neoplasm Recurrence, Local, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
